Skip to main content

Table 2 Characteristics of the seven patients with malignant tumors

From: Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO

No.

Age

Sex

Weight (kg)

FMISO activity (MBq)

DiFA activity (MBq)

DiFA mass (μg)

Diagnosis

1

68

M

65

394.2

703.1

0.338

Undifferentiated pleomorphic sarcoma

2

64

F

61

384.7

714.5

0.236

Small cell lung cancer

3

56

M

60

385.6

715.6

0.237

Rectal adenocarcinoma

4

63

F

51

374.6

725.2

0.277

Tongue squamous cell carcinoma

5

64

M

73

386.5

716.9

0.274

Liposarcoma

6

65

M

76

387.4

716.4

0.299

Hepatocellular carcinoma

7

48

F

52

386.5

733.3

0.306

Malignant melanoma

Mean

61.1 ± 6.3

 

62.6 ± 8.9

385.6 ± 5.4

717.9 ± 8.7

0.281 ± 0.034

Â